Fundamental XR builds case for wider surgical simulation adoption

Tern plc

Fundamental XR is demonstrating how virtual surgical simulation can be integrated directly into medical training, with its work alongside Orbis International showing how the technology is being used before trainees move into live procedures.

At Korle Bu Teaching Hospital in Ghana, first-year resident Dr Patrick Sapana-Kosa completed more than 80 MSICS procedures and over 25 hours of virtual simulation before operating on a patient. The purpose is straightforward: trainees can practise repeatedly, make mistakes and correct them before those mistakes carry real clinical consequences.

The programme is already being used at scale within the hospital. Thirteen first-year residents have completed more than 230 hours of simulation training this year. The training is not optional. Residents begin with virtual simulation, then progress to wet labs and finally to live cases. Embedding simulation into the curriculum increases its practical relevance and reduces the risk that the platform is treated as an occasional training tool.

Residents can learn basic surgical steps in simulation before entering wet labs, allowing faculty to spend less time teaching fundamentals and more time on advanced guidance. Fundamental XR says the approach has also reduced errors during wet-lab sessions, which can help limit waste of tissue and surgical supplies.

The same model is being used at the Rwanda International Institute of Ophthalmology. Participants there have reported improvements in how they perform individual surgical steps after using the simulator.

Orbis now connects 22 partner institutions across Africa, Asia and South America through the programme. Hundreds of early-stage surgeons have used the technology and completed thousands of hours of virtual practice.

That reach gives Fundamental XR an opportunity to show that its platform can be deployed across different institutions rather than remaining tied to a single hospital or training environment. Broader use also gives the company more opportunities to demonstrate whether simulation can become a repeatable part of surgical education.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Tern Plc launches £509,368 underwritten Open Offer

Tern Plc has announced an underwritten Open Offer to raise approximately £509,368 through the issue of 56.6 million shares at 0.90p each. Qualifying shareholders may subscribe for one new share for every 16 shares held, with the offer closing on 22 September 2026.

Talking Medicines targets a growing data need around GLP-1 treatment journeys

Talking Medicines is using GLP-1 discontinuation conversations to show how DrugVoice can help pharmaceutical companies track changing patient needs across the treatment journey.

Device Authority adopts usage-based pricing to support KeyScaler expansion

Device Authority has moved KeyScaler to usage-based pricing, aiming to reduce licensing friction and support broader adoption of its machine identity security platform.

Talking Medicines targets growing demand for GLP-1 patient intelligence

Talking Medicines is using GLP-1 patient conversations to show how behavioural data can help pharmaceutical companies understand changing treatment expectations and engagement.

Talking Medicines builds its AI strategy around specialist life sciences intelligence

Talking Medicines is positioning specialist healthcare intelligence as the core layer that gives agentic AI useful context in life sciences.

Device Authority targets cyber resilience opportunity at TechWorks Summit 2026

Device Authority will focus on continuous IoT and OT compliance, AI and quantum risk at TechWorks Summit 2026 as it strengthens its position in connected-device security.

Search